Yi‐Bin Chen

15.2k citations

197 papers · 4.9k indexed · 1 hit paper · h-index 35

Impact in

Hematology top 0.2%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
Genetics top 1%

Papers in

Hematology 118
- Hematopoietic Stem Cell Transplantation 88
- Acute Myeloid Leukemia Research 48
- Chronic Myeloid Leukemia Treatments 24
Genetics 43
- Chronic Lymphocytic Leukemia Research 19

Co-authors: Zachariah DeFilipp Ephraim P. Hochberg Elizabeth Hohmann Thomas R. Spitzer Michael K. Mansour Mariam Torres Soto Mohamad Sater Patricia P. Bloom
Journals: Blood (52 papers)Biology of Blood and Marrow Transplantation (47 papers)Transplantation and Cellular Therapy (13 papers)Journal of Clinical Oncology (10 papers)Bone Marrow Transplantation (8 papers)
Partner nations: United States Canada France

In The Last Decade

Yi‐Bin Chen

182 papers receiving 4.9k citations

Hit Papers

align trajectories log scale

Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant 2019 · 827 citations

Peers

Countries citing papers authored by Yi‐Bin Chen

Since Specialization

Citations

This map shows the geographic impact of Yi‐Bin Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi‐Bin Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi‐Bin Chen more than expected).

Fields of papers citing papers by Yi‐Bin Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi‐Bin Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi‐Bin Chen. The network helps show where Yi‐Bin Chen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yi‐Bin Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yi‐Bin Chen Line = papers co-authored together Yi‐Bin Chen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Phase II Study of Peri- and Post-Transplant Ruxolitinib for Patients With Myelofibrosis Receiving Allogeneic Hematopoietic Cell Transplantation Gabriela Hobbs, Haesook T. Kim, چنگیز سعدی پور, Mark A. Schroeder, Roni Tamari, Sarah Wall, Kerry Schneider, Areej El‐Jawahri, Matthew J. Frigault, Steven L. McAfee, Richard Newcomb, Paul V. O’Donnell, Thomas R. Spitzer, Jonas S. Jutzi, Yi‐Bin Chen, Zachariah DeFilipp	2025	1
2	RGI-2001 for the prophylaxis of acute graft-versus-host disease after allogeneic HCT Blood ·Zachariah DeFilipp, Hannah Choe, Yvonne A. Efebera, Ayman Saad, Ariel Liberman, Lazaros J. Lekakis, Jean A. Yared, Gary J. Schiller, Markus Y. Mapara, Amer Assal, Ted Gooley, Jack D. Bui, Eslam Elsayed, Mike Morey, Yi‐Bin Chen	2025	1
3	A phase I clinical trial of lenalidomide combined with bortezomib for acute myeloid leukemia or myelodysplastic syndrome relapsing after allogeneic stem cell transplantation Leukemia Research ·Brandon J. Aubrey, Traci M. Blonquist, Malgorzata McMasters, Gabriela Hobbs, Steven L. McAfee, Jacalyn Rosenblatt, Philip C. Amrein, Christine Connolly, Jae S. You, Emma Logan, Bimalangshu R. Dey, Thomas R. Spitzer, Р. С. Мартынов, Yi‐Bin Chen, Karen K. Ballen, Areej El‐Jawahri, Amir T. Fathi, Andrew M. Brunner	2025	1
4	Vedolizumab for prevention of lower-GI acute GVHD in the Japanese subgroup analysis of the phase 3 GRAPHITE study PubMed ·Tatsunori Goto, Hiroshi Okamura, Takashi Ikeda, Yasuo Mori, Souichi Shiratori, Shin‐ichiro Fujiwara, V. N. Sokov, Ken‐ichi Matsuoka, Yuta Katayama, Yi‐Bin Chen, Yngvar Fløisand, Guillermo Rossiter, Johan Jansson, Сукишева Марха Хамзатовна, Takanori Teshima	2025	1
5	Multisite Randomized Trial of Inpatient Palliative Care Intervention for Patients Undergoing Hematopoietic Stem Cell Transplantation Journal of Clinical Oncology ·Areej El‐Jawahri, Thomas W. LeBlanc, Alexandrina Machado Barbosa, Jason A. Webb, James Fausto, Lara Traeger, Joseph A. Greer, Vicki A. Jackson, Nora Horick, Dustin J. Rabideau, Martin Socher, Richard Newcomb, Nneka N. Ufere, 舒晓庆, 石岡俊之, Zachariah DeFilipp, Yi‐Bin Chen, Stephanie J. Lee, Jennifer S. Temel	2025	0
6	Design and Development of a Multimodal Digital Intervention (SHIFT App) to Address Sexual Dysfunction in Hematopoietic Stem Cell Transplant (HSCT) Survivors Transplantation and Cellular Therapy ·Richard Newcomb, Lara Traeger, 施卫祖, 浅田浩二, 沈杨, Jennifer Barsky Reese, Don S. Dizon, Sharon L. Bober, Joseph A. Greer, Shaikh Ha, Nicole Pensak, Zachariah DeFilipp, Yi‐Bin Chen, Jennifer S. Temel, Areej El‐Jawahri	2024	2
7	A phase 2 multicenter trial of ruxolitinib to treat bronchiolitis obliterans syndrome after allogeneic HCT Blood Advances ·Zachariah DeFilipp, Haesook T. Kim, Guang‐Shing Cheng, Betty K. Hamilton, Saurabh Chhabra, Mehdi Hamadani, Karamjeet Sandhu, Lia Perez, Catherine J. Lee, Kuchibhotla Satya Subrahmanya Sharma, ESSIEN OKU ESSIEN, Florence Nightingale David, Kathleen Gallagher, Richard Newcomb, Areej El‐Jawahri, Yi‐Bin Chen	2024	3
8	Vedolizumab for the prevention of intestinal acute GVHD after allogeneic hematopoietic stem cell transplantation: a randomized phase 3 trial Nature Medicine ·Yi‐Bin Chen, Mohamad Mohty, Robert Zeiser, Takanori Teshima, Omer Jamy, Johan Maertens, Duncan Purtill, Jingjing Chen, Hongcui Cao, Guillermo Rossiter, Johan Jansson, Yngvar Fløisand	2024	20
9	Spatial transcriptomics reveals distinct tissue niches linked with steroid responsiveness in acute gastrointestinal GVHD Blood ·Clélia Cristina Neves Pinto, Michael J. Raabe, Yoshinori Shirai, C.Y. Lawrence Lok, Chenyue Lu, Vikram Deshpande, Linda T. Nieman, Martin J. Aryee, Yi‐Bin Chen, David T. Ting, Zachariah DeFilipp	2023	0
10	Quality of Life, Physical Functioning, and Psychological Distress of Older Adults Undergoing Hematopoietic Stem Cell Transplantation Transplantation and Cellular Therapy ·Richard Newcomb, P. Connor Johnson, Carolina Camacho Ruiz, 広田口, H. Köppe, Kimia Ghanbari Mardasi, Diana Zamora Quintanilla, Dustin J. Rabideau, Zachariah DeFilipp, Yi‐Bin Chen, Areej El‐Jawahri	2023	10
11	Delirium and Healthcare Utilization in Patients Undergoing Hematopoietic Stem Cell Transplantation Transplantation and Cellular Therapy ·Hermioni L. Amonoo, Caique Assis das Neves, P. Connor Johnson, 真実濱崎, Sumant Patil, E. Altundag, Karimkhani, 広田口, Rafael Dahan, Kristie Gearty, Carolina Camacho Ruiz, Carlos Fernandez-Robles, William F. Pirl, Yi‐Bin Chen, Corey Cutler, Charlotta Lindvall, Areej El‐Jawahri	2023	2
12	Prolonged Post-Transplant Ruxolitinib Therapy is Associated with Protection from Severe Gvhd after Allogeneic HCT Transplantation and Cellular Therapy ·Zachariah DeFilipp, Haesook T. Kim, Laura Knight, Dr Rajendra Prasad H M, Michael Byrne, Mark A. Schroeder, Roni Tamari, Sarah Wall, Sumithira Vasu, Sameem Abedin, Areej El‐Jawahri, Steven L. McAfee, Yi‐Bin Chen, Gabriela Hobbs	2022	2
13	Phase II Trial of Eprenetapopt (APR-246) in Combination with Azacitidine (AZA) As Maintenance Therapy for TP53 mutated Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS) Following Allogeneic Hematopoietic Cell Transplantation (HCT) Transplantation and Cellular Therapy ·Asmita Mishra, Roni Tamari, Amy E. DeZern, Michael Byrne, Mahasweta Gooptu, Yi‐Bin Chen, H. Joachim Deeg, Karuna RAJKUMAR, Anders Wennborg, Denice Hickman, Eyal C. Attar, Hugo F. Fernández	2022	1
14	Acute GVHD Diagnosis and Adjudication in a Multicenter Trial: A Report From the BMT CTN 1202 Biorepository Study Journal of Clinical Oncology ·Ran Reshef, Wael Saber, Javier Bolaños‐Meade, George Chen, Yi‐Bin Chen, Vincent T. Ho, Doris M. Ponce, Ryotaro Nakamura, Michael J. Martens, John A. Hansen, John E. Levine	2021	15
15	A phase 2a randomized clinical trial of intravenous vedolizumab for the treatment of steroid-refractory intestinal acute graft-versus-host disease Bone Marrow Transplantation ·Yngvar Fløisand, Mark A. Schroeder, Patrice Chevallier, Dominik Selleslag, Steven M. Devine, Anne S. Renteria, Mohamad Mohty, Ibrahim Yakoub‐Agha, Chunlin Chen, Maria Fatima A. Villena, Syed M. Quadri, Johan Jansson, Mona Akbari, Yi‐Bin Chen	2021	11
16	A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease Blood Advances ·Mark A. Schroeder, H. Jean Khoury, Madan Jagasia, Haris Ali, Gary J. Schiller, Karl Staser, Jaebok Choi, Leah Gehrs, Michael Arbushites, Ying Yan, Peter Langmuir, I.S. Mihaylova, Michael A. Pratta, Miguel‐Angel Perales, Yi‐Bin Chen, Gabrielle Meyers, John F. DiPersio	2020	72
17	Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma Blood ·Matthew J. Frigault, Jörg Dietrich, María Martínez-Lage, Mark B. Leick, Bryan D. Choi, Zachariah DeFilipp, Yi‐Bin Chen, Jeremy S. Abramson, Jennifer L. Crombie, Philippe Armand, Lakshmi Nayak, Kátia Regina de Carvalho Balieiro, Lauren S. Riley, Kathleen Gallagher, Marcela V. Maus	2019	160
18	Fecal Microbiota Transplantation: Restoring the Injured Microbiome after Allogeneic Hematopoietic Cell Transplantation Biology of Blood and Marrow Transplantation ·Zachariah DeFilipp, Elizabeth Hohmann, Robert R. Jenq, Yi‐Bin Chen	2018	39
19	Allogeneic Hematopoietic Cell Transplantation for Aggressive NK Cell Leukemia. A Center for International Blood and Marrow Transplant Research Analysis Biology of Blood and Marrow Transplantation ·Mehdi Hamadani, Abraham S. Kanate, Alyssa DiGilio, Kwang Woo Ahn, Sonali M. Smith, Jong Wook Lee, Ernesto Ayala, Nelson J. Chao, Parameswaran Hari, Javier Bolaños‐Meade, Ronald E. Gress, Anders Gonҫalves da Silva, Yi‐Bin Chen, Umar Farooq, Gary J. Schiller, Jean A. Yared, Anna Sureda, Timothy S. Fenske, Horatiu Olteanu	2017	22
20	Selection of optimal alternative graft source: mismatched unrelated donor, umbilical cord blood, or haploidentical transplant Blood ·Karen K. Ballen, John Koreth, Yi‐Bin Chen, Bimalangshu R. Dey, Thomas R. Spitzer	2011	106

About Yi‐Bin Chen

Yi‐Bin Chen is a scholar working on Hematology, Genetics, Transplantation, Oncology and Immunology, having authored 197 papers that have together received 4.9k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (88 papers), Acute Myeloid Leukemia Research (48 papers), Acute Lymphoblastic Leukemia research (31 papers), Immune Cell Function and Interaction (26 papers), Chronic Myeloid Leukemia Treatments (24 papers), Lymphoma Diagnosis and Treatment (22 papers), Chronic Lymphocytic Leukemia Research (19 papers) and T-cell and B-cell Immunology (19 papers). The work is most often cited by research in Hematology (2.1k citations), Genetics (795 citations), Transplantation (176 citations), Oncology (1.5k citations) and Immunology (1.1k citations). Yi‐Bin Chen has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Zachariah DeFilipp, Ephraim P. Hochberg, Elizabeth Hohmann, Thomas R. Spitzer, Michael K. Mansour, Mariam Torres Soto, Mohamad Sater, Patricia P. Bloom, Sarah E. Turbett and Miriam Huntley. Their work appears in journals such as Blood, Biology of Blood and Marrow Transplantation, Transplantation and Cellular Therapy, Journal of Clinical Oncology and Bone Marrow Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact